v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity/Member’s Capital and Temporary Equity (Unaudited) - USD ($)
$ in Thousands
Total
Orbion
Solestial
Common Units
Common Stock
Common Stock
Orbion
Common Stock
Solestial
Additional paid-in-capital
Additional paid-in-capital
Orbion
Additional paid-in-capital
Solestial
Accumulated deficit
Accumulated other comprehensive income (loss)
Redeemable Preferred Units
Class P Units
Beginning balance (in shares) at Dec. 31, 2024                         56,619,831 0
Beginning balance at Dec. 31, 2024                         $ 68,413 $ 0
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Issuance of Redeemable preferred units (in shares)                         25,000,000  
Issuance of Redeemable preferred units                         $ 25,000  
Accretion of Class P Units                         $ 4,472  
Ending balance (in shares) at Jun. 30, 2025                         81,619,831 0
Ending balance at Jun. 30, 2025                         $ 97,885 $ 0
Beginning balance (in shares) at Dec. 31, 2024       1,078,929,080                    
Beginning balance at Dec. 31, 2024 $ 777,918     $ 963,213 $ 0     $ 0     $ (184,485) $ (810)    
Beginning balance (in shares) at Dec. 31, 2024         0                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accretion of Redeemable preferred units (4,472)     $ (4,472)                    
Foreign currency translation adjustment 857                     857    
Net loss (35,963)                   (35,963)      
Ending balance (in shares) at Jun. 30, 2025       1,078,929,080                    
Ending balance at Jun. 30, 2025 738,340     $ 958,741 $ 0     0     (220,448) 47    
Ending balance (in shares) at Jun. 30, 2025         0                  
Beginning balance (in shares) at Mar. 31, 2025                         56,619,831 0
Beginning balance at Mar. 31, 2025                         $ 70,522 $ 0
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Issuance of Redeemable preferred units (in shares)                         25,000,000  
Issuance of Redeemable preferred units                         $ 25,000  
Accretion of Class P Units                         $ 2,363  
Ending balance (in shares) at Jun. 30, 2025                         81,619,831 0
Ending balance at Jun. 30, 2025                         $ 97,885 $ 0
Beginning balance (in shares) at Mar. 31, 2025       1,078,929,080                    
Beginning balance at Mar. 31, 2025 764,565     $ 961,104             (196,214) (325)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accretion of Redeemable preferred units (2,363)     $ (2,363)                    
Foreign currency translation adjustment 372                     372    
Net loss (24,234)                   (24,234)      
Ending balance (in shares) at Jun. 30, 2025       1,078,929,080                    
Ending balance at Jun. 30, 2025 $ 738,340     $ 958,741 $ 0     0     (220,448) 47    
Ending balance (in shares) at Jun. 30, 2025         0                  
Beginning balance (in shares) at Dec. 31, 2025 240,956,348                       0 240,956,348
Beginning balance at Dec. 31, 2025 $ 143,115                       $ 0 $ 143,115
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Conversion of Class P Units into shares of common stock (in shares)         8,885,674                 (240,956,348)
Conversion of Class P Units into shares of common stock $ 302,113       $ 1     302,112           $ (143,307)
Accretion of Class P Units                           $ 192
Ending balance (in shares) at Jun. 30, 2026 0                       0 0
Ending balance at Jun. 30, 2026 $ 0                       $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2025 50,000,000     50,000,000                    
Beginning balance at Dec. 31, 2025 $ 867,824     $ 1,135,910 $ 0     0     (269,022) 936    
Beginning balance (in shares) at Dec. 31, 2025 0       0                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accretion of Redeemable preferred units $ (192)     $ (192)                    
Deemed dividend on conversion of the Class P Units into shares of common stock (60,722)             (60,722)            
Conversion of common units into shares of common stock (in shares)       (50,000,000) 97,411,398                  
Conversion of common units into shares of common stock 0     $ (1,135,718) $ 10     1,135,708            
Issuance of common stock in connection with IPO, net of underwriting discounts and commissions and other offering costs (in shares)         18,500,000                  
Issuance of common stock in connection with IPO, net of underwriting discounts and commissions and other offering costs 583,415       $ 2     583,413            
Issuance of common stock for acquisition of Orbion (in shares)           2,812,141 1,703,577              
Issuance of common stock for acquisition of Orbion   $ 60,180 $ 51,857           $ 60,180 $ 51,857        
Stock compensation expense 95,589             95,589            
Foreign currency translation adjustment (72)                     (72)    
Net loss $ (154,185)                   (154,185)      
Ending balance (in shares) at Jun. 30, 2026 0     0                    
Ending balance at Jun. 30, 2026                           $ 0
Ending balance (in shares) at Jun. 30, 2026 129,312,790       129,312,790                  
Beginning balance (in shares) at Mar. 31, 2026                         0 0
Beginning balance at Mar. 31, 2026                         $ 0  
Ending balance (in shares) at Jun. 30, 2026 0                       0 0
Ending balance at Jun. 30, 2026 $ 0                       $ 0 $ 0
Beginning balance (in shares) at Mar. 31, 2026       0                    
Beginning balance at Mar. 31, 2026 1,722,351     $ 0 $ 13     2,105,387     (383,864) 815   0
Beginning balance (in shares) at Mar. 31, 2026         127,609,213                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock for acquisition of Orbion (in shares)         1,703,577                  
Issuance of common stock for acquisition of Orbion 51,857             51,857            
Stock compensation expense 10,893             10,893            
Foreign currency translation adjustment 49                     49    
Net loss $ (39,343)                   (39,343)      
Ending balance (in shares) at Jun. 30, 2026 0     0                    
Ending balance at Jun. 30, 2026                           $ 0
Ending balance (in shares) at Jun. 30, 2026 129,312,790       129,312,790                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Ending Balance $ 1,745,807     $ 0 $ 13     $ 2,168,137     $ (423,207) $ 864